Where can I find the actual financial results for Eli Lilly in this filing?

The actual financial results for the quarter and year ended December 31, 2025, are detailed in the press release attached as Exhibit 99.1 to this 8-K filing. This press release is incorporated by reference into Item 2.02 of the report.

What is the significance of the filing date versus the event date?

The event date of February 3, 2026, is when the event (announcement of financial results) occurred. The filing date of February 4, 2026, is the date Eli Lilly officially submitted the 8-K report to the SEC, which includes the press release detailing these results.

Does this 8-K filing provide updated guidance for the upcoming fiscal year?

This 8-K filing primarily serves to announce the past period's results. Any forward-looking guidance or outlook for the upcoming fiscal year would be detailed within the incorporated press release (Exhibit 99.1) or subsequent investor communications. Investors should carefully review Exhibit 99.1 for any such guidance.

What does it mean that the information is 'furnished' and not 'filed' under Item 2.02?

When information is 'furnished' under Item 2.02, it means the company is providing it to the SEC, but it is not deemed 'filed' for the purposes of certain liability provisions, such as Section 18 of the Exchange Act. This is standard practice for earnings releases and does not affect the importance of the information for investors making investment decisions.

LLY 8-K: Earnings & Results

Summary

Eli Lilly and Company (LLY) filed a 8-K Current Report on February 4, 2026, to announce its financial results for the fourth quarter and full year ended December 31, 2025. The report primarily incorporates by reference a press release (Exhibit 99.1) containing these detailed financial outcomes. While the filing itself is brief, the associated press release is the critical document for investors seeking to understand the company's recent performance, including key revenue drivers, profitability, and any forward-looking statements or guidance provided by management.

Key Highlights

1Announcement of Q4 and Full Year 2025 financial results via press release.
2The 8-K filing incorporates Exhibit 99.1, the press release containing the financial details.
3Investors should refer to Exhibit 99.1 for specific revenue, earnings, and operational performance data for the period ending December 31, 2025.
4Information furnished under Item 2.02 is not considered 'filed' for Section 18 purposes, limiting its liability implications.
5The filing includes the cover page interactive data file in Inline XBRL format.

ELI LILLY & Co 8-K Report, Financial Results (Feb 4, 2026)

Summary

Key Highlights

Frequently Asked Questions